Silence Open To A Partner But Ready To Go It Alone On Lp(a) Drug

Rivals Novartis and Amgen are already in Phase III with Lp(a) drugs

 
• By Jessica Merrill
  
race
Silence is further behind Novartis and Amgen to develop a drug to treat Lp(a). • Source: Shutterstock

More from Cardiovascular

More from Therapy Areas